Chembio Diagnostic Systems is getting an infusion of $628,000 from the federal government to develop an antigen test for Covid-19 to more quickly and cheaply determine whether patients have the virus.
Antigen tests look for pieces of the proteins that make up SARS-CoV-2, the virus that causes Covid-19, to determine if someone is currently infected. The test typically uses a nasal or throat swab.
Chembio received the contract from the Biomedical Advanced Research and Development Authority. BARDA, part of the Department of Health and Human Services, helps develop countermeasures against emerging diseases.
The Food and Drug Administration has only authorized ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.